France· FR:64210260
GRAZAX 75 000 SQ-T, lyophilisat sublingual
A medicinal product containing extrait allergénique de pollen de fléole des prés, registered in France by ALK ABELLO (DANEMARK), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- EXTRAIT ALLERGÉNIQUE DE POLLEN DE FLÉOLE DES PRÉS
- Manufacturer
- ALK ABELLO (DANEMARK)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009378011643 plaquette(s) aluminium de 10 lyophilisat(s)EUR 59.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Extrait allergénique de pollen de fléole des prés in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCENTER-AL - PHLEUM PRATENSE POLLENALK-Abello, Inc.
- SwitzerlandAlutard SQ Phleum pratense
- United KingdomGrass mix pollen 5HEP solution for skin prick testDiater
- NetherlandsAlutard SQ Phleum pratense 100 - 100.000 SQ-E/ml, suspensie voor injectieALK-Abello A/S
- CanadaALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - TIMOTHYGREER LABORATORIES INC
- CzechiaALUTARD SQ BOJÍNEKALK-Abelló A/S, Horsholm
- GermanyPrick Test Lieschgras LetiLeti Pharma Gmbh
- ItalyGRAZAX*orale 30 liofilizzati 75.000SQ-TALK-ABELLO' A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Austria · Oraltek, Prick Test Lieschgras Leti
- Germany · Prick Test Lieschgras Leti, Provokationstest Lieschgras Leti
- Netherlands · Bencard, Prick Test Pollen Hal Allergy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d77c39e0-fa48-4241-8f54-717d1c3f103a GET /v1/drugs/d77c39e0-fa48-4241-8f54-717d1c3f103a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64210260",
"date_amm": "2007-02-08",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "EXTRAIT ALLERGÉNIQUE DE POLLEN DE FLÉOLE DES PRÉS",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "lyophilisat",
"voies_administration": "sublinguale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about extrait allergénique de pollen de fléole des prés.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.